AVEO Oncology to Present at the Lazard Capital Markets 9th Annual Healthcare Conference Business Wire CAMBRIDGE, Mass. -- November 06, 2012 AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Lazard Capital Markets 9th Annual Healthcare Conference on Tuesday, November 13, 2012 at 1:00 p.m. (ET) in New York City. A live webcast of AVEO’s presentation can be accessed by visiting the investors section of the company’s website at investor.aveooncology.com. A replay of the webcast will be archived on the AVEO website for two weeks following the presentation. About AVEO AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients' lives. AVEO's proprietary Human Response Platform^TM provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics. For more information, please visit the company's website at www.aveooncology.com. Contact: Investor Contact: AVEO Oncology Monique Allaire, 617-299-5810 or Media Contact: AVEO Oncology Rob Kloppenburg, 617-930-5595
AVEO Oncology to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.